Oxygen Therapy Device Market Research Report By Type (Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders, Portable Oxygen Devices, Oxygen Accessories), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Respiratory Distress Syndrome, Sleep Apnea, Cystic Fibrosis), By End Use (Hospitals, Home Care Settings, Emergency Medical Services, Long-term Care Facilities), By Technology (Continuous Flow Technology, Pulse Dose Technology, Hybrid Oxygen Therapy) and By Regional (North America, Europe, South America, Asia Pacific,

Oxygen Therapy Device Market Overview

As per MRFR analysis, the Oxygen Therapy Device Market Size was estimated at 3.15 (USD Billion) in 2023. The Oxygen Therapy Device Market Industry is expected to grow from 3.27(USD Billion) in 2024 to 5 (USD Billion) by 2035. The Oxygen Therapy Device Market CAGR (growth rate) is expected to be around 3.93% during the forecast period (2025 - 2035).

Key Oxygen Therapy Device Market Trends Highlighted

The Global Oxygen Therapy Device Market is witnessing significant trends driven by the increasing prevalence of respiratory diseases, the growing geriatric population, and rising awareness about oxygen therapy benefits. The surge in conditions such as chronic obstructive pulmonary disease (COPD) and asthma has heightened the demand for oxygen therapy devices across various healthcare settings, including hospitals and home care.
Additionally, the push for advanced healthcare technologies is driving innovation in device design and efficiency, catering to patient comfort and usability. Opportunities in the market are emerging from technological advancements in oxygen delivery systems.

Innovations like portable oxygen concentrators and high-flow nasal cannula systems are gaining traction, providing patients with improved mobility and ease of use. Furthermore, the increasing trend toward home healthcare solutions is reshaping the market landscape. Governments around the world are promoting home care systems to reduce hospital visits and enhance patient comfort. In recent times, there has been a noticeable shift towards digital health integration, with telemedicine and remote monitoring playing a pivotal role in oxygen therapy management. The ongoing COVID-19 pandemic has also accelerated this trend, as the need for effective respiratory support has come to the forefront.

This evolving market is characterized by a focus on personalized therapy and patient-centric approaches, enhancing treatment outcomes. As these trends continue to shape the Global Oxygen Therapy Device Market, collaboration between healthcare providers and technology developers will become increasingly essential to meet growing patient needs. Overall, the market presents a dynamic landscape for growth and innovation as stakeholders adapt to changing healthcare demands.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Oxygen Therapy Device Market Drivers

Rising Incidence of Respiratory Disorders

The rising incidence of respiratory conditions, including asthma and Chronic Obstructive Pulmonary Disease (COPD), is a major factor propelling the global oxygen therapy device market. The World Health Organization (WHO) estimates that respiratory illnesses take the lives of almost 3 million people each year, underscoring the urgent need for efficient oxygen treatment options. In addition, respiratory illnesses are predicted to rank as the third most common cause of death worldwide by 2030. 

By advocating for stronger oxygen therapy infrastructures and equipment, major organizations like the American Lung Association are indirectly driving market growth through their investments in awareness and treatment initiatives. The phase-out of old devices in favor of newer, more effective ones is becoming a key trend that will influence the future of the global oxygen therapy device market industry due to technological improvements and rising patient expectations.

Technological Advancements in Oxygen Devices

Technological advancements are rapidly changing the landscape of the Global Oxygen Therapy Device Market Industry. Innovations such as portable oxygen concentrators and advanced delivery systems are enhancing the accessibility and quality of oxygen therapy for patients. The European Union Medical Device Regulation has encouraged manufacturers to continuously improve their offerings, ensuring safety and efficacy while reducing costs. This progress is essential, given the projected increase in global elderly populations, expected to reach 1.5 billion by 2050.Enhanced devices cater to the needs of this demographic, driving further adoption and market expansion.

Growing Aging Population

The aging population globally is a considerable driver for the Global Oxygen Therapy Device Market Industry. According to the United Nations, by 2050, the number of people aged 60 years and older is expected to reach 2 billion, thereby increasing the demand for health services, including oxygen therapy. This demographic is more susceptible to respiratory issues, aggravating the need for effective treatment options. Organizations focusing on geriatric health are significantly influencing the market by promoting research and product innovation aimed at older adults, thus creating a thriving environment for oxygen therapy devices.

Oxygen Therapy Device Market Segment Insights

Oxygen Therapy Device Market Type Insights

The Global Oxygen Therapy Device Market, a critical segment within healthcare, is primarily segmented into several types, with each contributing uniquely to the overall market dynamics. In 2024, the market is valued at 3.27 USD Billion, demonstrating the growing demand for various oxygen delivery systems due to the rising prevalence of respiratory diseases and aging populations globally.
Dominating the market with significant value, the Oxygen Concentrators are projected to be valued at 1.25 USD Billion in 2024, reflecting a substantial majority holding due to their effectiveness and convenience for outpatient therapies, supporting the increasing need for long-term oxygen therapy.

Following closely, the Liquid Oxygen Systems, anticipated to reach 0.72 USD Billion by the same year, offer the advantages of portability and high oxygen capacity, appealing to users requiring a steady supply without the bulkiness of traditional devices.
Oxygen Cylinders, valued at 0.82 USD Billion in 2024, are noteworthy for their extensive usage in emergency situations and long-term care settings, providing a reliable alternative for various therapeutic applications, whereas Portable Oxygen Devices, targeting a smaller but significant share with a valuation of 0.45 USD Billion, address the needs of patients who require mobility while undergoing oxygen therapy, capitalizing on the trend towards home and remote healthcare solutions.

Lastly, Oxygen Accessories, although currently valued at a modest 0.03 USD Billion, play a vital role in enhancing patient experience and device functionality, driving additional revenues as they become an integral part of the therapy system. Overall, these segments collectively highlight the Global Oxygen Therapy Device Market’s diverse offerings, influencing industry growth with their tailored solutions to meet distinct healthcare needs while responding to evolving market trends and consumer demands.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Oxygen Therapy Device Market Application Insights

The Application segment of the Global Oxygen Therapy Device Market focuses on key areas, including Chronic Obstructive Pulmonary Disease, Asthma, Respiratory Distress Syndrome, Sleep Apnea, and Cystic Fibrosis. In 2024, the Global Oxygen Therapy Device Market is valued at USD 3.27 Billion, reflecting robust growth trends driven by an increase in respiratory conditions and an aging population. Chronic Obstructive Pulmonary Disease and Asthma are significant contributors to this market, as these conditions affect millions of individuals globally, necessitating effective oxygen therapies.

The prevalence of Respiratory Distress Syndrome, particularly in neonatal care, is another critical aspect, emphasizing the demand for specialized devices. Sleep Apnea treatment remains vital due to its high incidence, affecting a substantial portion of the adult population worldwide. Furthermore, Cystic Fibrosis management relies heavily on advanced oxygen therapy, showcasing the significance of this segment in addressing diverse respiratory health challenges. 

The combined insights of the Global Oxygen Therapy Device Market data reveal an evolving landscape where technological advancements and increasing healthcare spending are pivotal to market growth.As respiratory conditions continue to rise globally, opportunities within this segment remain promising, presenting avenues for innovation and enhanced patient care.

Oxygen Therapy Device Market End Use Insights

The Global Oxygen Therapy Device Market exhibits diverse applications across various end use settings, including Hospitals, Home Care Settings, Emergency Medical Services, and Long-term Care Facilities. In 2024, the overall market is valued at 3.27 USD Billion, reflecting the rising demand for oxygen therapy solutions driven by increasing respiratory disorders and an aging population. Hospitals play a critical role in this market, being primary centers for acute respiratory care, where advanced oxygen therapy devices are essential.

Home Care Settings have also gained significant traction as patients opt for at-home oxygen therapy, promoting independence and comfort. Emergency Medical Services are pivotal as they provide immediate respiratory support, often saving lives in critical situations. Long-term Care Facilities cater to chronic respiratory patients, necessitating sustained oxygen delivery solutions to ensure quality of life. The market's growth is propelled by the increasing prevalence of chronic obstructive pulmonary disease and other respiratory conditions, coupled with government initiatives to enhance healthcare access.

As such, the Global Oxygen Therapy Device Market segmentation illustrates a dynamic landscape poised for continued expansion.

Oxygen Therapy Device Market Technology Insights

The Global Oxygen Therapy Device Market, particularly focusing on the Technology segment, is witnessing significant growth, with a valuation of 3.27 USD Billion in 2024 and continuing to 5.0 USD Billion by 2035. The expected compound annual growth rate (CAGR) for the period from 2025 to 2035 stands at 3.93 percent.
Within this technology segment, Continuous Flow Technology is a prevalent choice, as it offers a steady stream of oxygen, making it essential for patients requiring constant oxygen supply.Meanwhile, Pulse Dose Technology is gaining traction due to its efficiency, delivering oxygen only during inhalation, thereby conserving resources and increasing comfort for users.

Additionally, Hybrid Oxygen Therapy represents a blend of both technologies, providing flexibility and versatility to meet diverse patient needs. The ongoing advancements in these technologies are driven by the rising prevalence of chronic respiratory diseases globally, coupled with an increasing aging population.
These factors pave the way for enhanced market growth, reflecting the overall Global Oxygen Therapy Device Market revenue and contributing to its dynamic market growth landscape. The improved functionality of these devices aligns with market trends that emphasize patient-centered care, optimizing both treatment outcomes and quality of life.

Oxygen Therapy Device Market Regional Insights

The Global Oxygen Therapy Device Market is poised for steady growth across its various regional segments, with a total market valuation of 3.27 billion USD in 2024. The North American segment holds a majority share, valued at 1.3 billion USD in 2024, and is expected to reach 2.0 billion USD by 2035, driven by advanced healthcare infrastructure and a high prevalence of respiratory diseases. Europe follows closely, with a market value of 1.0 billion USD in 2024, projected to grow to 1.5 billion USD by 2035, benefiting from increasing awareness and aging populations.

The Asia Pacific (APAC) region, valued at 0.75 billion USD in 2024, is experiencing rapid growth, anticipated to reach 1.2 billion USD by 2035, primarily due to rising healthcare accessibility and a growing elderly demographic. In contrast, South America and the Middle East and Africa (MEA) segments reflect smaller values, with South America at 0.15 billion USD and MEA at 0.07 billion USD in 2024; these markets are in earlier growth stages, yet they present significant opportunities due to emerging healthcare needs and investments in medical technology.

Overall, the Global Oxygen Therapy Device Market data reveals diverse regional dynamics with significant implications for market growth and development.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Oxygen Therapy Device Market Key Players and Competitive Insights

The Global Oxygen Therapy Device Market is characterized by a diverse array of products, services, and companies that play critical roles in the healthcare sector, addressing the growing incidence of respiratory diseases and the demand for oxygen therapy. The competition in this market is primarily driven by innovations in technology, the increasing prevalence of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory conditions, as well as an aging population that requires supportive healthcare solutions. 

Companies are exerting efforts to establish strong market positions through strategic collaborations, mergers and acquisitions, competitive pricing, and the development of advanced products designed for efficiency and patient comfort. As a result, the landscape is continually evolving, with various key players vying for market share and seeking to enhance their portfolios.AirSep Corporation holds a significant presence in the Global Oxygen Therapy Device Market, offering a range of innovative oxygen concentrators and delivery systems that cater to both home and hospital use. 

The company has established itself as a leader through its commitment to customer satisfaction and its ability to produce high-quality, reliable, and efficient oxygen therapy devices. The strengths of AirSep Corporation lie in its advanced technological capabilities, which allow for the development of compact and user-friendly systems that meet the diverse needs of patients. Furthermore, AirSep's robust distribution network and focus on research and development contribute to its competitive edge, enabling the company to respond swiftly to market trends and customer demands while continually enhancing its product offerings.

Fisher and Paykel Healthcare also makes a notable impact in the Global Oxygen Therapy Device Market, with a strong emphasis on providing innovative solutions for respiratory care, including heated humidification systems and CPAP devices. The company is recognized for its cutting-edge technologies that enhance patient comfort and optimize clinical outcomes. Its strengths include extensive research initiatives and a commitment to high-quality standards, solidifying its reputation in the industry. 

Fisher and Paykel Healthcare has a significant global market presence, supported by strategic partnerships and collaborations aimed at expanding its reach and enhancing service delivery. The company has engaged in various mergers and acquisitions to advance its technology and infrastructure, which strengthens its position in the competitive landscape and enables it to offer a comprehensive range of products that cater to diverse patient needs across the globe.

Key Companies in the Oxygen Therapy Device Market Include

• AirSep Corporation


• Fisher and Paykel Healthcare


• Invacare


• OxyGo


• GCE Group


• NIDEK


• ResMed


• Philips


• DeVilbiss Healthcare


• Vyaire Medical


• Breas Medical


• Medtronic


• Becton Dickinson


• Apex Medical


• Smiths Medical

Oxygen Therapy Device Market Industry Developments

The Global Oxygen Therapy Device Market has seen significant developments recently, including advancements in portable oxygen concentrators, which are becoming more popular due to their convenience and efficiency. Companies such as AirSep Corporation, Fisher and Paykel Healthcare, and Philips have reported increased demand for their innovative products, driven by a rise in respiratory disorders and an aging population. In terms of mergers and acquisitions, Invacare and OxyGo have recently strengthened their market positions through strategic partnerships aimed at expanding their product offerings. 

In October 2023, ResMed announced a collaboration with Vyaire Medical to enhance respiratory support technologies, which reflects the sector's focus on improving patient outcomes. Notably, the market experienced a valuation growth of over 12% from 2021 to 2023, attributed mainly to the COVID-19 pandemic, which heightened awareness of respiratory health. Companies like Medtronic and Becton Dickinson have also been making significant investments in Research and Development to introduce advanced oxygen delivery systems, addressing the ongoing need for effective respiratory treatments in the global healthcare landscape.

Oxygen Therapy Device Market Segmentation Insights

Oxygen Therapy Device Market Type Outlook

• Oxygen Concentrators


• Liquid Oxygen Systems


• Oxygen Cylinders


• Portable Oxygen Devices


• Oxygen Accessories

Oxygen Therapy Device Market Application Outlook

• Chronic Obstructive Pulmonary Disease


• Asthma


• Respiratory Distress Syndrome


• Sleep Apnea


• Cystic Fibrosis

Oxygen Therapy Device Market End Use Outlook

• Hospitals


• Home Care Settings


• Emergency Medical Services


• Long-term Care Facilities

Oxygen Therapy Device Market Technology Outlook

• Continuous Flow Technology


• Pulse Dose Technology


• Hybrid Oxygen Therapy

Oxygen Therapy Device Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	3.15(USD Billion)
MARKET SIZE 2024	3.27(USD Billion)
MARKET SIZE 2035	5.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	3.93% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	AirSep Corporation, Fisher and Paykel Healthcare, Invacare, OxyGo, GCE Group, NIDEK, ResMed, Philips, DeVilbiss Healthcare, Vyaire Medical, Breas Medical, Medtronic, Becton Dickinson, Apex Medical, Smiths Medical
SEGMENTS COVERED	Type, Application, End Use, Technology, Regional
KEY MARKET OPPORTUNITIES	Growing aging population demand, Increasing prevalence of respiratory diseases, Technological advancements in devices, Rising home healthcare adoption, Expanding healthcare infrastructure in emerging markets
KEY MARKET DYNAMICS	Increasing prevalence of respiratory diseases, Rising geriatric population, Technological advancements in devices, Growing home healthcare market, Favorable government initiatives
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA